About this episode

This episode discusses how digital biomarkers and AI-driven mobility analysis are transforming clinical care and drug development.

Digital biomarkers are turning everyday movement into clinically useful data, giving doctors a clearer picture of what’s happening between appointments, and giving pharma new ways to measure drug impact earlier and more precisely. In this episode, Dr Andree Bates interviews Dr Quique Llaudet , CEO and co-founder of Ephion Health , about precision monitoring and how AI-driven mobility analysis is changing both clinical care and drug development. Quique shares his journey from academic research into entrepreneurship, driven by a desire to turn science into real products that help patients. Ephion Health grew out of early work with paediatric hospitals in Barcelona, where sensor technology used in rehabilitation and exoskeleton projects revealed a bigger opportunity: objective, high-sensitivity gait and movement analysis that can detect disease signatures and track progression over time. The conversation breaks down what a digital biomarker actually is: a measurable signal of health captured via connected devices and analysed with digital methods. Ephion’s platform integrates multiple validated, off-the-shelf sensors to capture rich movement data in a short test, replacing blunt…

People in this episode

Host: Dr Andree Bates

Guest: Dr Quique Llaudet

Topics covered

• digital biomarkers
• precision monitoring
• AI in healthcare
• drug development
• mobility analysis

Mentioned in this episode

Organizations: Ephion Health

Places: Barcelona, paediatric hospitals

More episodes of AI For Pharma Growth

• E216: When AI meets Cell Engineering · May 5, 2026 · 31 min
• E214: Beyond Copilot · April 21, 2026 · 39 min
• E213: The Diagnostic Room: We have AI initiatives, but do we have a strategy? The quickest self-test · April 14, 2026 · 27 min
• E212: The Ethics of AI · April 7, 2026 · 18 min
• E210: Beyond Alzheimer’s: Scaling Digital Twins Across Disease Areas · March 24, 2026 · 32 min
• E209: Beyond Failure Prevention: How AI is Redesigning the Drug Discovery Pipeline · March 17, 2026 · 47 min

Explore listener stats, chart rankings, contacts and more on the AI For Pharma Growth podcast page.